Načítá se...
Inflammatory targets of therapy in sickle cell disease
Sickle cell disease (SCD) is a monogenic globin disorder characterized by the production of a structurally abnormal hemoglobin (Hb) variant Hb S, which causes severe hemolytic anemia, episodic painful vaso-occlusion and ultimately end-organ damage. The primary disease pathophysiology is intracellula...
Uloženo v:
| Vydáno v: | Transl Res |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4684475/ https://ncbi.nlm.nih.gov/pubmed/26226206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trsl.2015.07.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|